Neuroprotective action of tacrolimus (FK506) in focal and global cerebral ischemia in rodents: dose dependency, therapeutic time window and long-term efficacy
- 20 January 2003
- journal article
- Published by Elsevier in Brain Research
- Vol. 965 (1-2) , 137-145
- https://doi.org/10.1016/s0006-8993(02)04151-3
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Recommendations for Standards Regarding Preclinical Neuroprotective and Restorative Drug DevelopmentStroke, 1999
- Effect of immunosuppressant FK506 on ischemia-induced degeneration of hippocampal neurons in gerbilsLife Sciences, 1996
- Emerging treatments for stroke in humansTrends in Pharmacological Sciences, 1996
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Evaluation of the combination of a tissue-type plasminogen activator, SUN9216, and a thromboxane A2 receptor antagonist, vapiprost, in a rat middle cerebral artery thrombosis model.Stroke, 1993
- Penumbral tissues salvaged by reperfusion following middle cerebral artery occlusion in rats.Stroke, 1992
- Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexesCell, 1991
- Middle cerebral artery occlusion: correlation of computed tomography and angiography with clinical outcome.Stroke, 1987
- Delayed neuronal death in the gerbil hippocampus following ischemiaBrain Research, 1982
- Temporal profile of neuronal damage in a model of transient forebrain ischemiaAnnals of Neurology, 1982